He is the lead principal investigator of the ALLEGORY study and the lead author and he has also presented the results last Friday at SLEuro. Today, Dr. Richard Furie will take us again through the ...

Objective Biologics for systemic lupus erythematosus (SLE) demonstrate variable treatment responses across trials. We evaluated baseline biomarkers as predictors of response to guide personalised ...

C4 Therapeutics delivered strong 4Q25 results, with revenue up 111.5% YoY and operating expenses tightly controlled. Click for my latest analysis of CCCC stock.

New ChatGPT 5.4 Model Is 'Built for Agents.' Will It Lure Back Claude Converts?

Timothy Graham receives funding from the Australian Research Council (ARC) for the Discovery Project, 'Understanding and Combatting "Dark Political Communication"'. A new study published today in ...

As treatment strategies evolve in cutaneous lupus erythematosus (CLE), physicians are increasingly turning to advanced systemic therapies while evaluating emerging targeted options ...

5 Things to Know is CNBC's Morning Squawk newsletter, a before-the-bell briefing on the most important news, trends and analysis that investors need to start their trading day. Subscribe here to ...

If you're interested in exploring more stocks under $5 get an edge over other traders with Benzinga Pro while we're currently offering a 14-day trial. Searching for quality stocks under $5 is a lot ...

The Lakers and Hawks keep chugging along as big performances mark Monday's games and we preview Tuesday's matchups. Shai Gilgeous-Alexander and OKC stay hot, Cooper Flagg joins special company and we ...

Fox News is an independent company that does not claim any ownership of the term "Wordle". "Wordle" is only used for descriptive purposes and we do not claim any official association with Wordle. Our ...